ArticleMolecular neurodegeneration2025
Abstract read
In one paragraph
Article in Molecular neurodegeneration, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy.JAMA network open · 2026Article
- Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal Summit.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Retired contact sports athletes with cognitive concerns: promoting lifelong brain health.Practical neurology · 2026Review
- Common and rare variant analyses implicateNPJ dementia · 2026Article
- Quantitative Measurement of Tau Burden in a Dual-Time-Window Dynamic PET Imaging Protocol with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration.Frontiers in neurology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Michael L AloscoDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0002-8113-8428
Jhony Mejía PérezDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Julia E CulhaneDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Ranjani ShankarDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Christopher J NowinskiConcussion Legacy Foundation, Boston, MA, USA.
Samantha BureauConcussion Legacy Foundation, Boston, MA, USA.
Nidhi MundadaDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Karen SmithDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Alinda AmuiriDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Breton AskenDepartment of Clinical & Health Psychology, 1Florida Alzheimer's Disease Research Center, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA.
Jenna R GrohDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Annalise MinerDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Erika PettwayDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Sydney MosahebDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Yorghos TripodisDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Charles WindonDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Gustavo MercierMolecular Imaging and Nuclear Medicine, Boston Medical Center, Boston, MA, USA.
Robert A SternDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Lea T GrinbergDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
David N Soleimani-MeigooniDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Bradley T ChristianWisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Tobey J BetthauserWisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Thor D SteinDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Ann C McKeeDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Chester A MathisDepartment of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Eric E AbrahamsonDepartment of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Milos D IkonomovicDepartment of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sterling C JohnsonWisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Jesse MezDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Renaud La JoieDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Daniel SchonhautDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA.
Gil D RabinoviciDepartment of Neurology, Alzheimer's Disease Research Center, Memory & Aging Center, University of California San Francisco, San Francisco, CA, USA. Gil.Rabinovici@ucsf.edu.
Funding
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Julia K Kofler · 2020 to 2026
$29.4MRL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6MDevelopment of Emergent PET Tracers in Frontotemporal Lobar DegenerationK23AG076960 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David Nima Soleimani-Meigooni · 2022 to 2026
$951kIn Vivo Detection of Chronic Traumatic Encephalopathy with 18F-MK-6240 Tau PETR21NS120629 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALOSCO, MICHAEL, RABINOVICI, GIL DAN · 2021 to 2022
$461kNIA NIH HHS K23 AG076960NIA NIH HHS P30 AG066468NIA NIH HHS P30AG066468NIA NIH HHS P30 AG072978NIA NIH HHS P30AG072978NINDS NIH HHS R21 NS120629NINDS NIH HHS R21NS120629
Abstract
backgroundMolecular biomarkers of chronic traumatic encephalopathy (CTE) are lacking. We evaluated
methodsAutoradiography and in-vitro binding studies were done using
resultsAll six CTE stage III cases had Braak NFT stage III but no neuritic plaques. Two had Thal Phase 1 for Aβ; one showed a laminar pattern of
conclusionWe present evidence of
Indexed as
BrainChronic Traumatic EncephalopathyPositron-Emission Tomographytau ProteinsAgedAlzheimer DiseaseAutoradiographyFluorine RadioisotopesHumansIsoquinolinesMaleMiddle AgedFluorine RadioisotopesIsoquinolinesMK-6240tau ProteinsAlzheimer’s diseaseBiomarkersChronic traumatic encephalopathyMK-6240Repetitive head impactsTau PET
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.